Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis of observational studies

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 1, 2014, Pages 63-67

  Ungprasert, Patompong ^a   Suksaranjit, Promporn ^b   Spanuchart, Ittikorn ^c   Leeaphorn, Napat ^d   Permpalung, Nitipong ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Atherosclerosis; Coronary artery disease; Dermatomyositis; Idiopathic inflammatory myopathies; Meta analysis; Polymyositis

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; MYOSITIS; OBSERVATIONAL STUDY; POLYMYOSITIS; PRIORITY JOURNAL; RISK ASSESSMENT; STANDARDIZED INCIDENCE RATIO; SYSTEMATIC REVIEW; COMPLICATION; INCIDENCE; META ANALYSIS; RISK;

CORONARY ARTERY DISEASE; HUMANS; INCIDENCE; MYOSITIS; RISK;

EID: 84905216800     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.03.004     Document Type: Article

References (28)

1. Ungprasert P, Leeaphorn N, Hosiriluck N, Chaiwatcharayut W, Ammannagari N, Raddatz DA. Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in Asian population. ISRN Rheumatol 2013;2013:509354.
2. Bohan A., Peter J.B. Polymyositis and dermatomyositis-I. New Engl J Med 1975, 292:344-347.
3. Bohan A., Peter J.B. Polymyositis and dermatomyositis (second of tow parts). New Engl J Med 1975, 292:403-407.
4. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005, 25:1776-1785.
5. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
6. Maradit-Kremers H., Nicola P.J., Crowson C.S., Ballman K.V., Gabreil S.E. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005, 52:722-732.
7. Bessant R., Hingorani A., Patel L., MacGregor A., Isenberg D.A., Rahman A. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 2004, 43:924-929.
8. Vizzardi E., Raddino R., Teli M., Gorga E., Brambilla G., Dei Cas L. Psoriasis and cardiovascular diseases. Acta Cardiol 2010, 65:337-340.
9. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010, 25:603-605.
10. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in metaanalyses. Br Med J 2003, 327:557-560.
11. Tisseverasinghe A., Bernatsky S., Pineau C.A. Arterial events in persons with dermatomyositis and polymyositis. J Rheumatol 2009, 36:1943-1946.
12. Zoller B., Li X., Sundquist J., Sunquist K. Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One 2012, 7:e33442.
13. Lai Y.T., Dai Y.S., Yen M.F., Chen L.S., Chen H.H., Cooper R.G., et al. Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwanese population-based longitudinal follow up study. Br J Dermatol 2013, 168:1054-1059.
14. Linos E., Fiorentino D., Lingala B., Krishnan E., Chung L. Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of nationwide inpatient sample survey. Arthritis Res Ther 2013, 15:R7.
15. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
16. Montecucco F., Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 2009, 48:11-22.
17. Rho Y.H., Chung C.P., Oeser A., Solus J.F., Gebretsadik T., Shintani A., et al. Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res 2010, 62:1473-1480.
18. Niessner A., Sato K., Chaikof E.L., Colmegna I., Goronzy J.J., Weyand C.M. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in atherosclerotic plaque through interferon-alpha. Circulation 2006, 114:2482-2489.
19. Hansen S., Lassig G., Pistrosch E., Passauer J. Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity. Atherosclerosis 2003, 170:177-180.
20. Xu J., Lupu F., Esmon C.T. Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010, 30:8-9.
21. Esmon C.T. The interactions between inflammation and coagulation. Br J Haematol 2005, 131:417-430.
22. de Moraes M.T., de Souza F.H., de Barros T.B., Shinjo S.K. Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease. Arthritis Care Res 2013, 65:793-799.
23. Limaye V.S., Lester S., Blumbergs P., Roberts-Thompson P.J. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Int J Rheum Dis 2010, 13:132-137.
24. Wei L., MacDonald T.M., Walker B.R. Taking glucocorticoid by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004, 141:764-770.
25. Maradit-Kremers H., Reinalda M.S., Crowson C.S., Davis J.M., Hunder G.G., Gabriel S.E. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatic. Arthritis Rheum 2007, 57:279-286.
26. Toms T.E., Panoulas V.F., Douglas K.M., Griffitths H.R., Kitas G.D. Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2008, 10:R145.
27. Sholter D.E., Armstrong P.W. Adverse effects of corticosteroids on cardiovascular system. Can J Cardiol 2000, 16:505-511.
28. Voisard R., Seitzer U., Baur R., Dartsch P.C., Osterhues H., et al. Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro. Int J Cardiol 1994, 43:257-267.